Pulmonx (LUNG) : 2-year performance

 

IPOs this week : March 29 - Apr 1, 2021 (wk 13)

IPOs expected to price

• Compass (NYSE:COMP), 
• Frontier Group (NASDAQ:ULCC), 
• Coursera (COURS), 
• Kaltura (KLTR), 
• Karooooo (NASDAQ:KARO), 
• Muliang Viagoo Technology (OTC:MULG) and 
• Flora Growth (FLGC). 

IPO quiet period expirations

• Oscar Health (NYSE:OSCR) and Innovage (NASDAQ:INNV) on March 29,

IPO lockup expirations

• Chindata Group (NASDAQ:CD), 
• Yalla Group (NYSE:YALA), 
• Boqii Holding (NYSE:BQ), 
• Pulmonx (NASDAQ:LUNG), 
• Mission Produce (NASDAQ:AVO) and 
• Lixiang Education Holding (NASDAQ:LXEH).

Pulmonx (LUNG) began trading on the Nasdaq on Thur 1 Oct 20

Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. 

• Sector(s): Healthcare
• Industry: Medical Devices
• Full Time Employees: 253
• Incorporated in 1995 
• Headquartered in Redwood City, California
• https://pulmonx.com

Pulmonx  priced 10 mln share IPO at $19.00 per share, above the expected range of $17-18

IPOs this week : Sept. 28 - Oct. 2, 20 (wk 40)

IPOs expected to price

• The big debut of the week is Palantir Technologies (PLTR), which is expected to start trading in a direct listing on the NYSE on September 30. Bankers think the software/data analytics company could start off in the $10 range, which would give it a lush market cap of just under $22B. The Denver-based company lost $580M in 2019. 
• Academy Sports and Outdoors (ASO), 
• Asana (ASAN),  (direct listing?)
• Boqii Holding (BQ), 
• Chindata Group Holdings (CD),  (data centers?)
• Immunome (IMNM), 
• WiMi Hologram Cloud (NASDAQ:WIMI), 
• Mission Produce (AVO), 
• Pulmonx (LUNG) and 
• Yalla Group (YALA) 

IPO quiet period expirations

• PainReform (NASDAQ:PRFX) on September 29.